RSV in Adults: Who's Most at Risk and What Infectious Disease Specialists Recommend for Treatment

Respiratory syncytial virus (RSV) is often thought of as a childhood illness, but adults—especially certain groups—can also experience significant symptoms. In this article, we'll explain who's most at risk for RSV in adults, review symptoms and possible complications, and share treatment and prevention advice based on guidance from the CDC and the Infectious Diseases Society of America (IDSA).

If you're unsure about your symptoms or need quick guidance, try Ubie's free Medically approved LLM Symptom Checker Chat Bot for personalized health insights in minutes.

What Is RSV in Adults?

RSV is a common respiratory virus that infects the lungs and breathing passages. Most adults develop mild, cold‐like symptoms and recover in 1–2 weeks. However, for some, RSV can lead to serious problems like pneumonia or bronchitis.

Common symptoms in adults include:

• Runny nose or congestion
• Sore throat and cough
• Low‐grade fever (occasionally higher)
• Headache and muscle aches
• Fatigue or weakness
• Wheezing or shortness of breath (more common in severe cases)

Symptoms typically appear 4–6 days after exposure. Adults may shed virus and infect others for 3–8 days, sometimes longer in people with weakened immune systems.

Who's Most at Risk?

While healthy adults often recover quickly, these groups are at higher risk for severe RSV in adults:

• Older adults (65 years and older)
• People with chronic heart or lung diseases (e.g., COPD, asthma, congestive heart failure)
• Immunocompromised individuals (e.g., chemotherapy, organ transplant recipients, HIV)
• Residents of long‐term care facilities
• Adults with severe neurological or neuromuscular conditions
• Pregnant women (especially in late pregnancy)

Why these groups?

• Aging lowers immune responses.
• Chronic diseases can worsen lung function, making it harder to clear the virus.
• A weakened immune system can prolong infection and increase the chance of complications.

Potential Complications

In high‐risk adults, RSV can cause:

• Bronchiolitis (inflammation of small airways)
• Pneumonia (lung infection)
• Exacerbation of chronic lung diseases
• Respiratory failure requiring hospitalization

Even in healthy adults, RSV may lead to weeks of fatigue or prolonged cough. Rarely, it can trigger wheezing or asthma‐like symptoms.

What Infectious Disease Specialists Recommend for Treatment

There is no specific, widely approved antiviral for RSV in most adults. Treatment focuses on managing symptoms and supporting breathing. Key recommendations include:

1. Supportive Care

• Rest and reduce activity until breathing eases.
• Stay hydrated—drink water, broths, sports drinks to replace fluids.
• Use a humidifier to ease congestion and soothe airways.

2. Over‐the-Counter Medications

• Acetaminophen or ibuprofen for fever and aches.
• Decongestants or nasal saline sprays for congestion (use as directed).
• Cough syrups or lozenges to calm a sore throat or cough.

3. Monitoring and Home Oxygen

Adults at risk should monitor breathing and oxygen levels if possible. Pulse oximeters can help track oxygen saturation at home. Call your doctor if:

• Oxygen saturation drops below 92% on room air
• Breathing becomes rapidly more difficult
• New or worsening chest pain develops

4. Hospitalization and Advanced Support

Specialists recommend hospital care for severe cases, especially if:

• You have a chronic lung or heart condition and symptoms worsen
• You develop pneumonia or significant wheezing
• You need supplemental oxygen or ventilatory support

In the hospital, care may include:

• Supplemental oxygen or high‐flow nasal cannula
• Intravenous (IV) fluids if dehydration is severe
• Bronchodilators (inhalers or nebulizers) for wheezing
• Chest physiotherapy to help clear mucus

5. Antiviral Therapy (Select Cases)

Ribavirin, an antiviral, is rarely used but may be considered for:

• Immunocompromised adults
• Severe RSV pneumonia unresponsive to standard measures
  Use is guided by infectious disease specialists due to potential side effects and limited proven benefit in adults.

6. Monoclonal Antibodies and Vaccines

• Palivizumab is approved for high‐risk infants, not adults.
• Adult RSV Vaccines: In 2023, the FDA approved two RSV vaccines for adults aged 60 and older (manufactured by Pfizer and by GSK). Specialists recommend discussing vaccination with your doctor if you're in the high‐risk age group.

Talk with your healthcare provider about whether you qualify for vaccination this season.

Prevention Strategies

Stopping RSV spread is vital, especially around vulnerable adults. Key preventive steps:

• Wash hands frequently with soap and water for at least 20 seconds.
• Use alcohol‐based hand sanitizer when soap and water aren't available.
• Avoid touching your face (eyes, nose, mouth) with unwashed hands.
• Stay away from people who are coughing or sneezing.
• Wear a mask in crowded indoor settings during RSV season (fall through spring).
• Disinfect commonly touched surfaces (doorknobs, phones, countertops).
• Cover your mouth and nose with a tissue or your elbow when coughing or sneezing.

When to Seek Medical Help

RSV can mimic other respiratory illnesses (flu, COVID‐19). If you experience any of the following, seek medical attention promptly:

• Difficulty breathing or rapid breathing
• Chest pain or pressure
• Confusion or extreme drowsiness
• Bluish lips or face
• High fever unresponsive to OTC medications

If you're experiencing worrying symptoms but aren't sure whether they require urgent care, check them quickly using this Medically approved LLM Symptom Checker Chat Bot to help guide your next steps.

Talking to Your Doctor

Always inform your healthcare provider about:

• Existing medical conditions (heart, lung, immune system issues)
• Any medications you're taking
• Recent exposure to someone with a respiratory illness

Discuss whether you should:

• Be tested for RSV, influenza, or COVID‐19
• Receive supportive treatments at home
• Consider RSV vaccination or other preventive measures

Key Takeaways

• RSV in adults often feels like a cold but can be serious in older or chronically ill people.
• High‐risk adults include those over 65, with heart/lung disease, or a weakened immune system.
• Treatment focuses on rest, fluids, symptom relief, and oxygen support when needed.
• Ribavirin is rarely used; discuss monoclonal antibodies or vaccination with your doctor.
• Good hand hygiene, masks in crowded spaces, and surface cleaning help prevent infection.
• For uncertain symptoms, try this Medically approved LLM Symptom Checker Chat Bot to get AI‐powered health guidance anytime.
• Always speak to a doctor if you have life‐threatening symptoms or any serious concerns.

This information draws on guidance from the CDC and the Infectious Diseases Society of America. It's not a substitute for medical advice—if you have severe or concerning symptoms, please speak to a doctor right away.